Quick Takeaways
- Commodore Capital LP filed SCHEDULE 13G/A for Cardiff Oncology, Inc. Common Stock (CRDF).
- Disclosed ownership: 0%.
- Date of event: 30 Jun 2025.
Commodore Capital LP - 30 Jun 2025 SCHEDULE 13G/A Report for Cardiff Oncology, Inc. Common Stock (CRDF)
- Filing Manager
- Commodore Capital LP
- Reporting Manager
- Commodore Capital LP
- Security
- Cardiff Oncology, Inc. Common Stock
- Symbol
- CRDF
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 17:06:19 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 17 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Commodore Capital LP disclosed 0% ownership in Cardiff Oncology, Inc. Common Stock (CRDF) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 17 Dec 2024.
- Current filing was accepted on 14 Aug 2025, 17:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Commodore Capital LP | 0% | 0 | 0 | 0 | Michael Kramarz | Managing Partner | |
| Commodore Capital Master LP | 0% | 0 | 0 | 0 | Michael Kramarz | Authorized Signatory |